Janux Therapeutics (JANX) Current Deferred Revenue (2020 - 2026)
Janux Therapeutics (JANX) reported Current Deferred Revenue of $35.07 million for Q2 2026, down 6.7% from the prior quarter.
Powered by 
Analysis
Janux Therapeutics (JANX) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2023, Janux Therapeutics posted Current Deferred Revenue of $1.71 million, down 68.5% from FY2022.
- Current Deferred Revenue has a three-year compound annual growth rate of -4.4% (FY2020 to FY2023).
- By year, Current Deferred Revenue came in at $5.41 million in FY2022 (+4.7%), $5.16 million in FY2021 (+164.8%) and $1.95 million in FY2020.
- The Q2 2026 figure ranks as the lowest quarterly Current Deferred Revenue since Q2 2024.
- The high point for year-over-year Current Deferred Revenue in five years was Q4 2021 (growth of 164.8%); the low point was Q2 2024 (a decline of 98.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Janux Therapeutics | 1.06 Bn | 1.06 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.07 Mn |
| Mar 31, 2026 | 37.59 Mn |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | 972,000.00 |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 5.34 Mn |
| Mar 31, 2023 | 4.94 Mn |
| Dec 31, 2022 | 5.41 Mn |
| Sep 30, 2022 | 5.91 Mn |
| Jun 30, 2022 | 5.37 Mn |
| Mar 31, 2022 | 4.65 Mn |
| Dec 31, 2021 | 5.16 Mn |
| Sep 30, 2021 | 5.26 Mn |
| Jun 30, 2021 | 5.07 Mn |
| Dec 31, 2020 | 1.95 Mn |
API Access
Janux Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=JANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "JANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=JANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();